Background HIV-infected women are at increased risk for developing cervical cancer.
Women living in resource-limited countries are especially at risk due to poor access to …

Background Cervical cancer screening strategies using visual inspection or cytology may
have suboptimal diagnostic accuracy for detection of precancer in women living with HIV …

HIV and cervical cancer are intersecting epidemics in many low‐resource settings, yet there
are few accurate estimates of the scope of this public health challenge. To understand …

Background We systematically reviewed the diagnostic accuracy of cervical cancer
screening and triage strategies in women living with HIV (WLHIV). Methods Cochrane …

Objective To determine the optimal strategy for cervical cancer screening in women with
human immunodeficiency virus (HIV) infection by comparing two strategies: visual …

Objective: To determine the performance of molecular screening strategies for detection of
cervical intraepithelial neoplasia grade 3 or worse (CIN3+) in comparison with cytology …

Background: The careHPV assay is a test for high-risk (HR) human papillomaviruses (HPV)
detection designed to be affordable in resource-poor settings. We evaluated the …

Objective Women infected with human immunodeficiency virus (HIV) have a higher risk of
HPV infections and developing cervical cancer, thus screening them is imperative. This …

Background: A rigorous comparison of cervical cancer screening methods utilizing data on
immune status, antiretroviral therapy (ART) and colposcopy-directed biopsy has not been …

Objectives We sought to determine the clinical performance of visual inspection with acetic
acid (VIA), digital cervicography (DC), Xpert human papillomavirus (HPV), and OncoE6 for …